background image

Non-Alcoholic Steatohepatitis (NASH) Clinical Trials

Find clinical trials for non-alcoholic steatohepatitis (nash). Search for non-alcoholic steatohepatitis (nash) clinical trials in different cities and states across the United States.

Filter
1
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

for
NASH With Fibrosis, MASH With Fibrosis
Location: 143 recruiting locations
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06215716

Phase3, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

for
NASH - Nonalcoholic Steatohepatitis,
Location: 130 recruiting locations
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06528314

Phase3, Recruiting
Active & Responsive

Statins for the Treatment of NASH

for
NASH - Nonalcoholic Steatohepatitis
Location: 1 recruiting location
Sponsor: Mayo Clinic

Sex: All

Age: 18 - 70

Code: NCT04679376

Phase2, Recruiting
Active & Responsive

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)

for
Obesity, Non-Alcoholic Fatty Liver Disease,
Location: 1 recruiting location
Sponsor: Bettina Mittendorfer

Sex: All

Age: 18 - 70

Code: NCT06571474

Recruiting
Active & Responsive

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

for
Non-alcoholic Fatty Liver Disease
Location: 1 recruiting location
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07221227

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Fibrosis Lessens After Metabolic Surgery

for
Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD),
Location: 1 recruiting location
Sponsor: Ali Aminian

Sex: All

Age: 18 - 70+

Code: NCT06374875

Recruiting

A Study to Evaluate the Safety and Tolerability of Single and Multiple Ascending Doses of HPN-01 in Healthy Subjects

for
Non-Alcoholic Steatohepatitis (NASH)
Location: 1 recruiting location
Sponsor: Hepanova Inc.

Sex: All

Age: 18 - 55

Code: NCT04481594

Phase1, Recruiting

Evaluation of Miricorilant on Liver Fat in Patients With MASLD

for
Nonalcoholic Steatohepatitis (NASH),
Location: 1 recruiting location
Sponsor: Corcept Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06947304

Phase1, Recruiting

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis,
Location: 113 recruiting locations
Sponsor: 89bio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06318169

Phase3, Recruiting

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

for
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis,
Location: 107 recruiting locations
Sponsor: 89bio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06419374

Phase3, Recruiting